Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclooctane SCHEMBL28098731 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| Cyclohexane SCHEMBL7376420 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| Cycloheptane SCHEMBL27831919 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| Ether SCHEMBL232500 | 1.00 | — | — | |
| Cyclohexane SCHEMBL2297628 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| Cyclohexane SCHEMBL8441380 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| Cyclohexane SCHEMBL251247 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| Cyclohexane SCHEMBL2292997 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| Cyclohexane SCHEMBL8441382 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| Cyclohexane SCHEMBL9286703 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240328682-A1 | Laminate for Color Radiative Cooling and Radiative Cooling Material Including the Same | HYUNDAI MOTOR COMPANY (KR) | 2024-10-03 | — | — | US | claimed |
| US-5625067-A | Cyclopentane ether derivatives, processes for their production, and their pharmaceutical use | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-04-29 | — | — | US | claimed |
| EP-0558570-B1 | CYCLOPENTANE ETHER DERIVATIVES, METHODS FOR PREPARING THEM AND THEIR USE IN PHARMACEUTICALS | SCHERING AG (DE) | 1996-01-10 | — | — | EP | claimed |
| US-12606684-B2 | Footwear mold system for injection-molding | NIKE, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| US-12583990-B2 | Footwear component manufacturing system | NIKE, INC. (US) | 2026-03-24 | — | — | US | disclosed |
| US-12583991-B2 | Foam compositions and uses thereof | NIKE, INC. (US) | 2026-03-24 | — | — | US | disclosed |
| US-20260001984-A1 | HIGH STRAIN HARDENING POLYETHER-ESTER MATERIAL APPLICABLE TO ELASTIC FIBER | SHINKONG SYNTHETIC FIBERS CORP (TW) | 2026-01-01 | — | — | US | disclosed |
| EP-3442642-B1 | METHOD OF MAKING A CATETHER ASSEMBLY | BOSTON SCIENT SCIMED INC (US) | 2025-10-15 | — | — | EP | disclosed |
| US-20250311809-A1 | METHODS FOR COMPRESSION MOLDING FOAM ARTICLES | NIKE, INC. | 2025-10-09 | — | — | US | disclosed |
| US-12426670-B2 | Midsole structure of an article of footwear including mesh | NIKE, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| EP-4117881-B1 | FOOTWEAR COMPONENT MANUFACTURING SYSTEM | NIKE INNOVATE CV (US) | 2025-08-20 | — | — | EP | disclosed |
| US-5328933-A | Occular hypotensives | ALLERGAN, INC. (US) | 1994-07-12 | — | — | US | disclosed |
| WO-1994010141-A1 | CYCLOPENTANE HEPTENYLNITRO AND HEPTANYLNITRO-2-ALIPHATIC OR ARYLALIPHATIC DERIVATIVES AND HOMOLOGOUS | ALLERGAN, INC. (US) | 1994-05-11 | — | — | WO | disclosed |
| WO-1992009573-A3 | CYCLOPENTANE ETHER DERIVATIVES, METHODS FOR PREPARING THEM AND THEIR USE IN PHARMACEUTICALS | SCHERING AG (DE) | 1994-01-06 | — | — | WO | disclosed |
| WO-1992009573-A3 | CYCLOPENTANE ETHER DERIVATIVES, METHODS FOR PREPARING THEM AND THEIR USE IN PHARMACEUTICALS | SCHERING AG (DE) | 1994-01-06 | — | — | WO | disclosed |
| EP-0558570-A1 | CYCLOPENTANE ETHER DERIVATIVES, METHODS FOR PREPARING THEM AND THEIR USE IN PHARMACEUTICALS. | SCHERING AG (DE) | 1993-09-08 | — | — | EP | disclosed |
| WO-1992009573-A2 | CYCLOPENTANE ETHER DERIVATIVES, METHODS FOR PREPARING THEM AND THEIR USE IN PHARMACEUTICALS | SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) | 1992-06-11 | — | — | WO | disclosed |
| WO-1992009573-A2 | CYCLOPENTANE ETHER DERIVATIVES, METHODS FOR PREPARING THEM AND THEIR USE IN PHARMACEUTICALS | SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) | 1992-06-11 | — | — | WO | disclosed |
| US-4479990-A | Arc and track resistant articles utilizing photosensitive sag resistant cycloaliphatic epoxy resin coating compositions | WESTINGHOUSE ELECTRIC CO. (US) | 1984-10-30 | — | — | US | disclosed |
| US-4102851-A | THIXOTROPIC | WESTINGHOUSE ELECTRIC CORP. (US) | 1978-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260001984-A1 | HIGH STRAIN HARDENING POLYETHER-ESTER MATERIAL APPLICABLE TO ELASTIC FIBER | ZRANB2, ZKSCAN2, ZNF787 | ALDH1A1 3909/4885TSHR 2131/4885 |
| US-12583990-B2 | Footwear component manufacturing system | BRAF, RPTOR, ARAF | ALDH1A1 3885/4885TSHR 1374/4885 |
| US-12606684-B2 | Footwear mold system for injection-molding | POLR1C, NACA, PIK3C3 | ALDH1A1 4648/4885TSHR 1069/4885 |
| US-12583991-B2 | Foam compositions and uses thereof | CUTA, SUCLG1, RAD51 | ALDH1A1 3765/4885TSHR 4154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.